Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2013-02-26 19:01:01 UTC |
---|
Update Date | 2023-02-21 17:29:17 UTC |
---|
HMDB ID | HMDB0059734 |
---|
Secondary Accession Numbers | - HMDB0060645
- HMDB59734
- HMDB60645
|
---|
Metabolite Identification |
---|
Common Name | Pyrazin-2-carboxylic acid |
---|
Description | Pyrazin-2-carboxylic acid, also known as pyrazinoic acid or pyrazinoate, belongs to the class of organic compounds known as pyrazine carboxylic acids. These are heterocyclic compounds containing a pyrazine ring substituted by one or more carboxylic acid groups. Pyrazin-2-carboxylic acid is an extremely weak basic (essentially neutral) compound (based on its pKa). Pyrazin-2-carboxylic acid exists in all living organisms, ranging from bacteria to humans. These are heterocyclic compounds containing a pyrazine ring substituted by one or more carboxylic acid group. |
---|
Structure | InChI=1S/C5H4N2O2/c8-5(9)4-3-6-1-2-7-4/h1-3H,(H,8,9) |
---|
Synonyms | Value | Source |
---|
2-Carboxypyrazine | ChEBI | 2-Pyrazinecarboxylic acid | ChEBI | Paradiazinecarboxylic acid | ChEBI | Pyrazinecarboxylic acid | ChEBI | Pyrazinemonocarboxylic acid | ChEBI | Pyrazinic acid | ChEBI | Pyrazinoic acid | ChEBI | 2-Pyrazinecarboxylate | Generator | Paradiazinecarboxylate | Generator | Pyrazinecarboxylate | Generator | Pyrazinemonocarboxylate | Generator | Pyrazinate | Generator | Pyrazinoate | Generator | Pyrazin-2-carboxylate | Generator | Pyrazine-2-carboxylic acid | MeSH | Pyrazine-2-carboxylate | Generator |
|
---|
Chemical Formula | C5H4N2O2 |
---|
Average Molecular Weight | 124.0975 |
---|
Monoisotopic Molecular Weight | 124.027277382 |
---|
IUPAC Name | pyrazine-2-carboxylic acid |
---|
Traditional Name | pyrazinoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC(=O)C1=CN=CC=N1 |
---|
InChI Identifier | InChI=1S/C5H4N2O2/c8-5(9)4-3-6-1-2-7-4/h1-3H,(H,8,9) |
---|
InChI Key | NIPZZXUFJPQHNH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrazine carboxylic acids. These are heterocyclic compounds containing a pyrazine ring substituted by one or more carboxylic acid groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrazines |
---|
Direct Parent | Pyrazine carboxylic acids |
---|
Alternative Parents | |
---|
Substituents | - Pyrazine carboxylic acid
- Heteroaromatic compound
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Pyrazin-2-carboxylic acid EI-B (Non-derivatized) | splash10-0fc0-9100000000-0d1d9343efa8efa99226 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Pyrazin-2-carboxylic acid EI-B (Non-derivatized) | splash10-0fc0-9100000000-0d1d9343efa8efa99226 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pyrazin-2-carboxylic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ul0-9300000000-5d851f8b3e99335027a5 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pyrazin-2-carboxylic acid GC-MS (1 TMS) - 70eV, Positive | splash10-05fr-9700000000-dc1a24b248b553898896 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pyrazin-2-carboxylic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 10V, Positive-QTOF | splash10-004i-0900000000-9e64f2293e46344d81ed | 2015-09-14 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 20V, Positive-QTOF | splash10-004i-2900000000-af86c6152381383e33e7 | 2015-09-14 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 40V, Positive-QTOF | splash10-0uk9-9000000000-cafc4cffd9f796c532e5 | 2015-09-14 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 10V, Negative-QTOF | splash10-00di-2900000000-576cc0731c2413e5e0d6 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 20V, Negative-QTOF | splash10-00fr-9800000000-d888658b0a8673ea88fe | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 40V, Negative-QTOF | splash10-0fvi-9000000000-eb742c3177bfe29f72e5 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 10V, Negative-QTOF | splash10-004i-9000000000-90831ac2a79e645518ba | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 20V, Negative-QTOF | splash10-004i-9000000000-90831ac2a79e645518ba | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 40V, Negative-QTOF | splash10-0ufr-9000000000-11eb44f98f6f9300db58 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 10V, Positive-QTOF | splash10-004i-2900000000-fc721474e0fad99dcba0 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 20V, Positive-QTOF | splash10-004i-9100000000-3bc909318a437df6cd91 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pyrazin-2-carboxylic acid 40V, Positive-QTOF | splash10-0udi-9000000000-c78d399db63d85709c22 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 1018 |
---|
KEGG Compound ID | C19915 |
---|
BioCyc ID | PYRAZINOIC-ACID |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Pyrazinoic_acid |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 1047 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 71311 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Knope KE, Kimura H, Yasaka Y, Nakahara M, Andrews MB, Cahill CL: Investigation of in situ oxalate formation from 2,3-pyrazinedicarboxylate under hydrothermal conditions using nuclear magnetic resonance spectroscopy. Inorg Chem. 2012 Mar 19;51(6):3883-90. doi: 10.1021/ic3000944. Epub 2012 Feb 24. [PubMed:22360688 ]
- Dolezal M, Zitko J, Kesetovicova D, Kunes J, Svobodova M: Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation. Molecules. 2009 Oct 20;14(10):4180-9. doi: 10.3390/molecules14104180. [PubMed:19924056 ]
- Aoki Y, Yoshida M, Kawaide H, Abe H, Natsume M: Structural determination of hypnosin, a spore germination inhibitor of phytopathogenic Streptomyces sp. causing root tumor in melon (Cucumis sp.). J Agric Food Chem. 2007 Dec 26;55(26):10622-7. Epub 2007 Dec 5. [PubMed:18052243 ]
- Nakanishi T, Ohya K, Shimada S, Anzai N, Tamai I: Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate. Nephrol Dial Transplant. 2013 Mar;28(3):603-11. doi: 10.1093/ndt/gfs574. Epub 2013 Jan 4. [PubMed:23291366 ]
- Bansal G, Singh M, Jindal KC, Singh S: LC and LC-MS study on establishment of degradation pathway of glipizide under forced decomposition conditions. J Chromatogr Sci. 2008 Jul;46(6):510-7. [PubMed:18647472 ]
- Vishweshwar P, Nangia A, Lynch VM: Recurrence of carboxylic acid-pyridine supramolecular synthon in the crystal structures of some pyrazinecarboxylic acids. J Org Chem. 2002 Jan 25;67(2):556-65. [PubMed:11798330 ]
- Ma C, Han Y, Zhang R, Wang D: Self-assembly of diorganotin(IV) moieties and 2-pyrazinecarboxylic acid: syntheses, characterizations and crystal structures of monomeric, polymeric or trinuclear macrocyclic compounds. Dalton Trans. 2004 Jun 21;(12):1832-40. Epub 2004 May 13. [PubMed:15381988 ]
- Dolezal M, Kesetovic D, Zitko J: Antimycobacterial evaluation of pyrazinoic acid reversible derivatives. Curr Pharm Des. 2011;17(32):3506-14. [PubMed:22074423 ]
- Sato M, Wakayama T, Mamada H, Shirasaka Y, Nakanishi T, Tamai I: Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats. Biochim Biophys Acta. 2011 Jun;1808(6):1441-7. doi: 10.1016/j.bbamem.2010.11.002. Epub 2010 Nov 11. [PubMed:21074513 ]
- Holzer W, Eller GA, Datterl B, Habicht D: Derivatives of pyrazinecarboxylic acid: 1H, 13C and 15N NMR spectroscopic investigations. Magn Reson Chem. 2009 Jul;47(7):617-24. doi: 10.1002/mrc.2437. [PubMed:19402051 ]
- Nayak S, Harms K, Dehnen S: New three-dimensional metal-organic framework with heterometallic [Fe-Ag] building units: synthesis, crystal structure, and functional studies. Inorg Chem. 2011 Apr 4;50(7):2714-6. doi: 10.1021/ic1019636. Epub 2011 Mar 1. [PubMed:21361297 ]
- Tanase S, Marques Gallego P, Bouwman E, Long GJ, Rebbouh L, Grandjean F, de Gelder R, Mutikainen I, Turpeinen U, Reedijk J: Versatility in the binding of 2-pyrazinecarboxylate with iron. Synthesis, structure and magnetic properties of iron(II) and iron(III) complexes. Dalton Trans. 2006 Apr 7;(13):1675-84. Epub 2005 Dec 15. [PubMed:16547543 ]
- Dolezal M, Palek L, Vinsova J, Buchta V, Jampilek J, Kralova K: Substituted pyrazinecarboxamides: synthesis and biological evaluation. Molecules. 2006 Mar 29;11(4):242-56. [PubMed:17962755 ]
- Sato M, Mamada H, Anzai N, Shirasaka Y, Nakanishi T, Tamai I: Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human. Biol Pharm Bull. 2010;33(3):498-503. [PubMed:20190416 ]
- Servusova B, Eibinova D, Dolezal M, Kubicek V, Paterova P, Pesko M, Kralova K: Substituted N-benzylpyrazine-2-carboxamides: synthesis and biological evaluation. Molecules. 2012 Nov 6;17(11):13183-98. doi: 10.3390/molecules171113183. [PubMed:23132136 ]
- Cuevas A, Kremer C, Hummert M, Schumann H, Lloret F, Julve M, Faus J: Magnetic properties and molecular structures of binuclear (2-pyrazinecarboxylate)-bridged complexes containing Re(IV) and M(II) (M = Co, Ni). Dalton Trans. 2007 Jan 21;(3):342-50. Epub 2006 Nov 21. [PubMed:17200754 ]
- Dolezal M, Zitko J, Osicka Z, Kunes J, Vejsova M, Buchta V, Dohnal J, Jampilek J, Kralova K: Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated N-phenylpyrazine-2-carboxamides. Molecules. 2010 Nov 26;15(12):8567-81. doi: 10.3390/molecules15128567. [PubMed:21116226 ]
|
---|